COVID-19: US Govt Gobbles Up 150 Million BinaxNOW Rapid Tests From Abbott
Abbott will be paid $760m for the tests under a contract with the Department of Health and Human Services and the Department of Defense.
You may also be interested in...
Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.
The BinaxNOW COVID-19 Ag Card portable lateral flow test, which delivers rapid results with no instrumentation, could be a “game changer” in the effort to reopen schools and other crowded places.
The US agency has announced four more webinars aimed at labs and manufacturers that are (or have) developed diagnostic tests for the novel coronavirus.